Rezultati pretraživanja
  1. 14. sij

    Enfortumab Vedotin Approved for Recurrent Bladder Cancer - National Cancer Institute ⁦⁩

    4 korisnika označavaju da im se sviđa
  2. 3. sij

    Should pelvic nodes be irradiated in N0 in the context of ? Whole-Pelvis or Bladder-Only Chemoradiation for Lymph Node–Negative Invasive Bladder Cancer: Single-Institution Experience

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
  3. 2. velj

    INTERESTING TRIAL trying to determine if adjuvant RTP can benefit patients post cystectomy to achive local control. Discussion must include not just an “yes or not answer” but also fields and dosis!!

    Still an important question in the context of negative data from IMVIGOR 010 study
  4. 9. sij

    Less than 1 week to submit LOI in for Innovation award from . Apply now!

    2 korisnika označavaju da im se sviđa
  5. 6. sij

    More and more data from confirming the benefits and safety of neoadjuvant Pembro.

    Again from : Prospective Assessment of Perioperative Surgical safety from the PURE-01 Trial. Use of criteria

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.